Skip to main content
. 2021 Feb 16;4(5):e202000904. doi: 10.26508/lsa.202000904

Figure 3. Method implementation on SARS-CoV-2.

Figure 3.

(A) Receiver operating characteristic curve evaluating predictive power of network-based approach in ranking drugs currently under investigation for COVID-19 in clinical trials. (B) Box and whisker plot of network mean scores generated for all drugs with a non-zero value and for drugs identified by the sequence similarity approach. (C) Visualization of predicted antiviral drugs and SARS-CoV-2 Protein Data Bank structures on the virus–host–similarity interaction network.